CORONA Remedies Limited (NSE:CORONA)
1,388.30
-70.50 (-4.83%)
At close: Jan 21, 2026
CORONA Remedies Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 539.6 | 32.23 | 31.56 | 144.94 | 68.24 | 47.89 |
Short-Term Investments | - | 8.16 | 13.98 | 59.69 | 69.92 | 676.94 |
Cash & Short-Term Investments | 539.6 | 40.39 | 45.54 | 204.63 | 138.16 | 724.83 |
Cash Growth | - | -11.31% | -77.75% | 48.11% | -80.94% | - |
Accounts Receivable | 1,601 | 1,183 | 999.34 | 869.91 | 743.52 | 2,072 |
Other Receivables | - | 6.14 | 4.02 | 2.67 | 5.98 | 0.62 |
Receivables | 1,603 | 1,193 | 1,007 | 876.96 | 753.73 | 2,076 |
Inventory | 1,073 | 1,295 | 983.45 | 1,054 | 739.47 | 306 |
Prepaid Expenses | - | 37.03 | 33.85 | 27.59 | 17.3 | 2.96 |
Other Current Assets | 243.3 | 823.71 | 829.22 | 751.7 | 1,187 | 147.72 |
Total Current Assets | 3,459 | 3,389 | 2,899 | 2,915 | 2,836 | 3,258 |
Property, Plant & Equipment | 4,049 | 3,847 | 3,116 | 2,488 | 1,665 | 1,437 |
Long-Term Investments | 259.6 | 259.53 | 275 | 399.86 | 437.77 | 360.61 |
Other Intangible Assets | 1,680 | 1,712 | 1,927 | 5.34 | 95.3 | 207.28 |
Long-Term Deferred Tax Assets | - | - | - | 42.52 | 37.83 | 42.21 |
Other Long-Term Assets | 318.6 | 91.77 | 87.76 | 99.94 | 42.08 | 11.77 |
Total Assets | 9,766 | 9,299 | 8,306 | 5,950 | 5,114 | 5,316 |
Accounts Payable | 1,408 | 1,435 | 1,143 | 943.7 | 846 | 720.42 |
Accrued Expenses | - | 94.69 | 67.41 | 88.41 | 69.62 | 87.93 |
Short-Term Debt | - | 106.95 | 311.42 | 23.31 | 20.67 | 47.52 |
Current Portion of Long-Term Debt | 395.8 | 360 | 360 | - | 151.33 | 133.03 |
Current Portion of Leases | 28.5 | 25.2 | 21.65 | 17.92 | 58.43 | 42.02 |
Current Income Taxes Payable | 138.7 | 63.25 | 48.05 | 38.32 | 33.8 | 58.24 |
Other Current Liabilities | 453.3 | 310.61 | 290.44 | 262.05 | 298.61 | 257.4 |
Total Current Liabilities | 2,424 | 2,396 | 2,242 | 1,374 | 1,478 | 1,347 |
Long-Term Debt | - | 160 | 670 | - | 165.38 | 318.21 |
Long-Term Leases | 202.8 | 210.16 | 226.48 | 238.37 | 68.24 | 66.81 |
Long-Term Unearned Revenue | - | - | 0.14 | 4.91 | 4.91 | - |
Pension & Post-Retirement Benefits | - | 135.98 | 109.55 | 76.53 | 56.56 | 45.98 |
Long-Term Deferred Tax Liabilities | 99.3 | 82.95 | 42.86 | - | - | - |
Other Long-Term Liabilities | 443.6 | 250.16 | 210.74 | 171.52 | 131.02 | 160.35 |
Total Liabilities | 3,170 | 3,235 | 3,502 | 1,865 | 1,905 | 1,938 |
Common Stock | 611.6 | 611.6 | 611.6 | 611.6 | 510.51 | 46.41 |
Additional Paid-In Capital | - | 415.84 | 415.84 | 415.84 | 411.97 | 967.88 |
Retained Earnings | - | 5,036 | 3,777 | 3,058 | 2,283 | 2,360 |
Comprehensive Income & Other | 5,985 | - | - | - | - | 0.09 |
Total Common Equity | 6,597 | 6,063 | 4,804 | 4,085 | 3,205 | 3,374 |
Shareholders' Equity | 6,597 | 6,063 | 4,804 | 4,085 | 3,209 | 3,378 |
Total Liabilities & Equity | 9,766 | 9,299 | 8,306 | 5,950 | 5,114 | 5,316 |
Total Debt | 627.1 | 862.31 | 1,590 | 279.6 | 464.05 | 607.6 |
Net Cash (Debt) | -87.5 | -821.92 | -1,544 | -74.97 | -325.89 | 117.23 |
Net Cash Per Share | -1.43 | -13.44 | -25.25 | -1.29 | -6.38 | 1.92 |
Filing Date Shares Outstanding | 61.19 | 61.16 | 61.16 | 61.16 | 51.05 | 51.05 |
Total Common Shares Outstanding | 61.19 | 61.16 | 61.16 | 61.16 | 51.05 | 51.05 |
Working Capital | 1,035 | 992.77 | 657.24 | 1,541 | 1,358 | 1,911 |
Book Value Per Share | 107.80 | 99.14 | 78.55 | 66.80 | 62.78 | 66.10 |
Tangible Book Value | 4,917 | 4,352 | 2,877 | 4,080 | 3,110 | 3,167 |
Tangible Book Value Per Share | 80.35 | 71.16 | 47.04 | 66.71 | 60.92 | 62.04 |
Land | - | 81.79 | 81.79 | 81.79 | 81.79 | 81.79 |
Buildings | - | 479.37 | 475 | 472.35 | 464.4 | 449.25 |
Machinery | - | 1,606 | 1,427 | 1,248 | 984.82 | 857.22 |
Construction In Progress | - | 1,860 | 1,206 | 647.09 | 142.29 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.